Phosphotyrosine phosphatase (PTPase) activity in rat liver was measured using a phosphopeptide substrate containing sequence identity to the major site of insulin receptor autophosphorylation. PTPase activity was detected in both cytosolic and particulate fractions of rat liver and produced linear dephosphorylation over a 15-min time course. In rats made insulin-deficient diabetic by streptozotocin treatment (STZ), cytosolic PTPase activity increased to 180% of the control values after 2 d of diabetes and remained elevated at 30 d (P < 0.02). Gel filtration on Sephadex-75 revealed a single peak of activity in the cytosol in both control and diabetic animals and confirmed the increased levels. In BB diabetic rats, another model of insulin deficiency, the PTPase activity in the cytosolic frac- 
Introduction
Phosphorylation of tyrosine residues in cellular proteins is an important regulatory process (1) . The insulin receptor and the receptors for several other hormones and growth factors possess intrinsic tyrosine protein kinase activity (2) (3) (4) (5) . Furthermore, an increasing body of evidence suggests that tyrosine phosphorylation plays a central role in the cellular action of growth factors receptors and oncogene products (6) (7) (8) . By contrast, the physiological role of dephosphorylation of tyrosine residues by specific phosphotyrosine protein phosphatases (PTPases)I has not been well elucidated. Specific PTPases were first described in preparations of membranes in 1981 by Brautigan et al. (9) and Gallis et al. (10) . Simultaneously, cytosolic forms of PTPase were identified in extracts of muscle and liver by Folkes et al. (1 1) . In subsequent studies, PTPase activity has been detected in a variety of tissues and cell lines, both in the soluble and particulate fractions (12-18). These enzymes are distinct from phosphoserine phosphatases based on their specificity for substrates containing phosphotyrosine residues, activity in the presence of EDTA, and selective inhibition by micromolar concentration of zinc.
Little is known about the role of PTPases in physiologic and in disease states. Two lines of evidence drew our attention to the possible role of altered PTPase in diabetes. The first is the observation that in most (19, 20) , but not all (22, 23) studies, insulin receptor autophosphorylation and kinase activity is decreased in animal models of type I diabetes such as streptozotocin (STZ) rats (19, 20) and BB diabetic rats (20) in spite of increases in insulin receptor concentration. An insulin receptor defect is also one component of peripheral resistance to insulin in patients with type II diabetes. In liver, Caro et al. (24) reported defects in both insulin receptor number and tyrosine kinase activity in hepatocytes isolated from obese type II diabetics. Three recent studies have demonstrated defects in the tyrosine kinase activity of the insulin receptor in adipose tissue (25) (26) (27) and in human skeletal muscle tissue (28) . Such alterations in tyrosine phosphorylation could result from a decrease in the intrinsic activity of the insulin receptor kinase or from an increase in the rate of dephosphorylation of phosphotyrosine residues. The second is the fact that vanadium, a potent tyrosine PTPase inhibitor, mimics insulin effects in isolated cells (reviewed in 29) and in STZ diabetic rats (30, 31 ). This insulin-like effect of vanadate may be due to inhibition of PTPases (32, 33) or a direct stimulation of the insulin receptor autophosphorylation (34) .
In light of these findings, we measured PTPase activity in the liver, an important insulin responsive tissue, in two models of insulin deficient diabetes. Since cells may contain multiple PTPase activities that differ in their substrate specificity (35), we have focused our attention on the PTPase activity which may be involved in insulin receptor dephosphorylation by utilizing a synthetic substrate containing sequence identity to the major site of insulin receptor autophosphorylation, residues 1142-1153 in the insulin receptor sequence (3) Hepes (pH 7.4), 5 mM Mn2+, 0.1% Triton X-100, with or without insulin (1,000 ng/ml). These mixtures were incubated at 22°C for 10 min. The phosphorylation reaction was initiated by adding 'y[32P]ATP and terminated by adding fivefold concentrated Laemmli sample buffer. The mixture was heated immediately in boiling water for 3 min. The proteins were separated in 7.5% polyacrylamide gel electrophoresis according to Laemmli (40) . The gels were stained with Coomassie blue in 50% TCA, destained in 7% acetic acid, dried, and subjected to autoradiography. The incorporation of 32p into the 95-kD , 8- MCi y[32P]ATP for 1 h at 4°C. The reaction mixture was desalted by gel filtration chromatography using Bio-rad P-6. The dephosphorylation of the partially purified insulin receptor was assayed in the presence of 2 mM EDTA, 1 mM DTT, PMSF (0.0025% wt/vol), 0.5 mM benzamidine, 25 Mg/ml leupeptin, and 5 Mg/ml aprotinin. After incubation at 30°C with buffer or with equal amounts of tissue extract from control or STZ-treated rats for the indicated periods of time, the reaction was stopped by boiling in Laemmli buffer containing 100 mM DTT and proteins were separated by 7.5% polyacrylamide gel electrophoresis (40) . The gel was stained and were subjected to autoradiography. The incorporation of 32p into the 95-kD ,B-subunit band was quantified by scanning densitometry.
PTPase assay. The mixture of WGA-purified insulin receptor and phosphorylated peptide substrate was heated at 55°C for 10 min to inactivate any kinase or phosphatase activity in the mixture (36) . Phosphotyrosine phosphatase activity in tissue extracts was assayed by incubation with 40 Ml oftissue extract diluted in 25 mM Hepes, pH 7.0, 1 mM EDTA, 1 mM DTT and 0.0025% wt/vol PMSF with 10 Ml substrate mixture. The dephosphorylation reaction was carried out at 30°C and was terminated by the addition of 50 Ml ice-cold 5% TCA and 20 Ml 1% BSA. After incubation at 0°C and centrifugation to remove precipitated proteins, the supernatant containing the soluble peptide was applied to phosphocellulose paper and subjected to four 1 5-min washes in 75 mM phosphoric acid. The radioactivity remaining in the paper-bound peptide was determined by Cherenkov radiation (37). The activity of the enzyme sample was calculated by comparing the dephosphorylation of the peptide substrate by tissue extracts to that observed with buffer alone. 1 U of PTPase activity was defined as the amount of enzyme releasing 1 pmol [32p]pi per min. The reaction was linear with respect to time (Fig. 1) , substrate concentration and enzyme concentration up to 50% of substrate hydrolysis. In subsequent experiments, the dephosphorylation assay was conducted for 10 min.
Analytic methods. Blood glucose levels were determined using (23) . 40 Mul of tissue extract diluted in 25 mM Hepes pH 7.0, 1 mM EDTA, 1 mM DTT and 0.0025% wt/vol PMSF, were incubated with 10 ul of the substrate mixture. The dephosphorylation reaction was carried out at 300C and was terminated by the addition of 50 ,l 5% TCA and 20 ,ul BSA 1% wt/vol at the indicated times. 32P-labeled peptide was collected by filtration in phosphocellulose paper and incorporation of phosphate into the substrate was determined by Cerenkov radiation (37). The enzyme activity was calculated by comparing 32p content after incubation with the tissue extracts with the 32p content after incubation with the buffer alone. markedly increased, while the ratio of serum insulin concentration to blood glucose levels was markedly decreased in both models of insulin-deficient diabetes (Table I) . 3 d of treatment with vanadate or insulin normalized blood glucose levels, but liver weight and body weight remained decreased in the vanadate-treated STZ-diabetic rats (Table I) .
Effect ofSTZ diabetes on receptor autophosphorylation. An autoradiogram showing in vitro phosphorylation of WGA purified extracts derived from the livers of STZ-diabetic rats (8 d duration) and control rats is presented in Fig. 2 A and quantified in B. For each group, both basal and insulin stimulated incorporation of 32p into the 95-kD 13-subunit of the insulin receptor was examined. Insulin stimulation of solubilized insulin receptor autophosphorylation was decreased to 55% of the control values, similar to previous studies from our laboratory and others ( 19, 20 (Fig. 3) . To determine if the increase in activity was associated with a new species of PTPase, cytosolic samples from 30-d STZ-diabetic rats and their controls were analyzed by gel-filtration chromatography on G-75 Sephadex. PTPase activity from both extracts eluted as a single peak of activity at Mr = 20-25 kD (data not shown). When the column fractions were assayed, peak activity derived from diabetic sample was 4.9-fold higher than control (14.1 vs. 2.9 U/mg protein).
To determine if this increase in PTPase activity could affect insulin receptor autophosphorylation in STZ-diabetic rats, we assayed PTPase activity directly using the WGA-purified insulin receptors which had undergone autophosphorylation in vitro. When equal amounts of cytosolic protein were used from control and STZ-diabetic rats (8 d duration), the preparation from diabetic rats dephosphorylated the insulin receptor 13-subunit at about twice the rate of the control (Fig. 4, A  and B) .
Particulate fractions obtained from STZ diabetic rats and controls were also assayed for tyrosyl-specific PTPase activity after solubilization in 1% Triton X-100 (Fig. 5) Effect of treatment on PTPase activity. We examined the effects of two types oftreatment on PTPase activity in the liver of STZ-diabetic rats. 5 d after induction of STZ diabetes rats were treated with insulin (14 U/rat per d, two-thirds of the dose in the morning and one-third in the afternoon) or with vanadate (0.6 mg/ml) included in the drinking water. In the vanadate-treated rats and their controls 75 mM NaCl was included in the drinking water to reduce vanadate toxicity, as previously described (30, 31 Insulin-deficient diabetes in STZ-induced or BB diabetic rats is associated with a blunted response to insulin stimulation of glucose transport, glucose oxidation, and lipogenesis in several tissues including skeletal and heart muscle (42), adipose tissue (44) (45) (46) , and liver (47, 48) , despite increased insulin binding (44, 45, 48) . The decrease in insulin action is associated with decreases in both receptor autophosphorylation and activity of the receptor tyrosine kinase (19, 20 In the present study, we have assayed cytosolic and membrane-associated phosphotyrosine phosphatase activity in liver utilizing a synthetic phosphopeptide substrate which contains sequence identify to the major site of insulin receptor autophosphorylation (3). We find that in two different animal models of type I diabetes mellitus there is an early increase in cytosolic and membrane PTPase activity. In the case of membrane PTPase activity, these changes are time dependent and can be affected by treatment with insulin or vanadate. Although a synthetic substrate was used in these studies for improved quantitation, the tissue preparations were also active in dephosphorylation of the autophosphorylated insulin receptor itself under the same assay conditions. Thus, an increase in PTPase activity may contribute to a decrease in insulin receptor activation through a reduced level of tyrosine autophosphorylation. In addition, the increased PTPase activity may decrease the phosphotyrosine content of endogenous substrates of the insulin receptor kinase. Identification of such substrate(s) will facilitate the studying of the relevant tyrosine PTPase.
Although the exact relationship between the cytosolic and membrane PTPase activities is uncertain, some differences were noted when we compared diabetes-related changes in the two compartments. First, after 30 d ofdiabetes we observed an increase in the cytosolic PTPase activity both in the STZ and BB diabetic rats, whereas the PTPase activity associated with the particulate fraction was slightly decreased in these animals at the same time. In addition, we observed that 3 d of treatment of STZ diabetic rat with insulin or vanadate markedly reduced the PTPase activity in the particulate fraction, but had no effect on the PTPase activity of the cytosolic fraction.
Previous work (17) has suggested that in the kidney, a membrane-bound PTPase can be distinguished from its cytosolic counterpart based on differential elution from DEAESepharose, thermal lability and sensitivity to dodecyl sulfate. On the other hand, Tonks et al. ( 15) reported that little difference could be detected between the cytosolic and particulate forms of the enzyme purified from human placenta. Since our data indicate that PTPase activity of the two fractions are affected differently by type I diabetes and its treatment, more detailed studies of the relationship of these two forms of the enzymes are warranted. The specific factors regulating PTPase activity and their mechanisms of action are unknown. The insulin receptor is an insulin-activated tyrosine-specific protein kinase (2) (3) (4) (5) protein kinase C (49-51). An insulin stimulated redistribution of the Mg ATP-dependent multifunctional protein phosphatase activator has also been demonstrated in human platelets (54, 55) . Change in the activation state of a PTPase inhibitor (52, 53) could provide a third possible mechanism. Protein inhibitors of serine phosphoprotein phosphatases have been well documented (reviewed in 1), and some preliminary studies suggest the presence of PTPase inhibitors as well ( 15) .
The treatment of the STZ-diabetic rats either with insulin or with vanadate significantly decreases the membrane-associated PTPase activity. While any of the above mechanisms could potentially mediate the insulin effect, vanadate has been shown to be a strong inhibitor of PTPase activity at concentrations that do not inhibit phosphoserine and phosphothreonine phosphatases (55, 56) . Some groups have found that vanadate also directly stimulates ,8-subunit tyrosine autophosphorylation and in vitro phosphotransferase activity of purified insulin receptors (34) , but this has not been observed in all studies (33). Based on previous studies, treatment with vanadate at the concentrations used here should produce a vanadate serum concentration of -7 7,M (31). This vanadate concentration will inhibit the PTPase activity in both of the cytosol and particulate fractions of the liver preparation almost completely in vitro (data not shown). This concentration c 10 Figure 6 . PTPase activ- date (0.6 mg/ml with 75 mM NaCI) or with drinking water with 75 mM NaCl alone. PTPase activity from the rat livers was assayed as described in Fig. 2 . The left panel describes the PTPase activity in the particulate fractions derived from control rats and the right panel the particulate fraction derived from STldiabetic rats with and without treatment. The results represent mean±SEM of five rats in each group assayed in duplicate in three separate experiments. * P < 0.05.
is significantly lower than the vanadate concentration reportedly effective in stimulating insulin receptor autophosphorylation in vitro (34) . This suggests that the normalization of serum glucose levels by vanadate in STZ-diabetic rats is more likely due to its inhibitory effects on PTPase rather than a direct stimulation of insulin receptor kinase activity. Thus, the modulation of PTPase activity with vanadate may prove to be an additional tool in the treatment of insulin resistance states.
